SEC Form 4Coverage since Jun 1, 2026
$XERS insider trading
Over the last 12 months, Xeris Biopharma Holdings insiders reported no purchases and 10 sales totaling $2.0M across SEC Form 4 filings. 100% of the activity was filed under pre-arranged 10b5-1 trading plans.
- Bought · 12m
- — 0 events
- Sold · 12m
- $2.0M 10 events
- Events · 12m
- 10 Form 4 filings, grouped
- Insiders · 12m
- 7 distinct reporters
- 10b5-1 share
- 100% pre-arranged plans
Side
Price · $XERS · 12Mvia TradingView
Top insiders · 12m
Hecht BethSee Remarks3× · $368K
McCulloch KevinSee Remarks2× · $843K
JOHNSON JOHN—1× · $91K
PERSKY MARLA—1× · $91K
BORMANN-KENNEDY BARBARA-JEAN ANNE—1× · $98K
All insider trades
10 events
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Aug 3, 2026 | McCulloch KevinSee Remarks · O | ▼ Sale | 15,000 | $8.02 | $120K | -0.9% | plan |
| Aug 3, 2026 | Hecht BethSee Remarks · O | ▼ Sale | 16,666 | $8.01 | $134K | -1.4% | plan |
| Jul 7, 2026 | Pieper StevenSee Remarks · O | ▼ Sale | 45,000 | $8.52 | $383K | -3.2% | plan · 2 tranches |
| Jul 1, 2026 | McCulloch KevinSee Remarks · O | ▼ Sale | 90,000 | $8.03 | $723K | -5.1% | plan |
| Jul 1, 2026 | Hecht BethSee Remarks · O | ▼ Sale | 16,666 | $8.03 | $134K | -1.4% | plan |
| Jun 4, 2026 | HALKUFF DAWND | ▼ Sale | 20,000 | $6.09 | $122K | -17.4% | plan |
| Jun 4, 2026 | BORMANN-KENNEDY BARBARA-JEAN ANNED | ▼ Sale | 16,000 | $6.09 | $98K | -11.2% | plan |
| Jun 4, 2026 | JOHNSON JOHND | ▼ Sale | 15,000 | $6.09 | $91K | -2.1% | plan |
| Jun 3, 2026 | PERSKY MARLAD | ▼ Sale | 15,500 | $5.9 | $91K | -10.9% | plan |
| Jun 1, 2026 | Hecht BethSee Remarks · O | ▼ Sale | 16,667 | $6.06 | $101K | -1.4% | plan |
About Form 4
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $XERS feed.